• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌与十二指肠溃疡复发——一项为期12个月的随访研究。

Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

作者信息

Coghlan J G, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, Keane C, O'Morain C

机构信息

Department of Gastroenterology, Meath, Adelaide.

出版信息

Lancet. 1987 Nov 14;2(8568):1109-11. doi: 10.1016/s0140-6736(87)91545-5.

DOI:10.1016/s0140-6736(87)91545-5
PMID:2890019
Abstract

In 39 patients with endoscopically healed duodenal ulcers repeat endoscopy and two antral biopsies after 1 year showed a relapse rate of 59%. Only post-treatment Campylobacter pylori status was a significant predictor of endoscopic relapse. 79% of patients who remained culture positive had a relapse, compared with 27% of culture-negative patients. Relapse was more likely (66%) in patients with a recurrence of C pylori after apparent eradication of the organism than in those who remained negative for C pylori (10%). No patient who remained negative for C pylori had histological gastritis, whereas all with recurrence of C pylori showed histological gastritis. These findings suggest an important role for C pylori in duodenal ulcer relapse in the year after treatment.

摘要

在39例十二指肠溃疡经内镜检查已愈合的患者中,1年后重复内镜检查及两次胃窦活检显示复发率为59%。仅治疗后幽门螺杆菌状态是内镜复发的显著预测因素。培养仍为阳性的患者中有79%复发,而培养阴性的患者复发率为27%。在幽门螺杆菌明显根除后又复发的患者中,复发可能性更大(66%),而幽门螺杆菌仍为阴性的患者复发率为10%。幽门螺杆菌仍为阴性的患者均无组织学胃炎,而所有幽门螺杆菌复发的患者均有组织学胃炎。这些发现提示幽门螺杆菌在治疗后1年内十二指肠溃疡复发中起重要作用。

相似文献

1
Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.幽门螺杆菌与十二指肠溃疡复发——一项为期12个月的随访研究。
Lancet. 1987 Nov 14;2(8568):1109-11. doi: 10.1016/s0140-6736(87)91545-5.
2
Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.幽门螺杆菌根除后十二指肠溃疡复发的前瞻性双盲试验
Lancet. 1988;2(8626-8627):1437-42. doi: 10.1016/s0140-6736(88)90929-4.
3
Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication.根除幽门螺杆菌后十二指肠溃疡的复发及幽门螺杆菌感染
Med J Aust. 1989 Oct 16;151(8):431-5. doi: 10.5694/j.1326-5377.1989.tb101251.x.
4
Cure of duodenal ulcer after eradication of Helicobacter pylori.根除幽门螺杆菌后十二指肠溃疡的治愈情况。
Med J Aust. 1990 Aug 6;153(3):145-9. doi: 10.5694/j.1326-5377.1990.tb136833.x.
5
Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori.硫糖铝和西咪替丁对十二指肠溃疡相关性胃窦炎及幽门弯曲菌的作用。
Am J Med. 1989 Jun 9;86(6A):60-5. doi: 10.1016/0002-9343(89)90159-9.
6
Natural history of Campylobacter pylori in duodenal ulceration treated with an H2-antagonist.用H2拮抗剂治疗十二指肠溃疡时幽门螺杆菌的自然史。
Aliment Pharmacol Ther. 1989 Jun;3(3):315-20. doi: 10.1111/j.1365-2036.1989.tb00218.x.
7
Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.通过联合使用枸橼酸铋胶体预防幽门螺杆菌对硝基咪唑的耐药性:临床和体外研究
J Clin Pathol. 1988 Feb;41(2):207-10. doi: 10.1136/jcp.41.2.207.
8
Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.十二指肠溃疡中的组织学胃炎:与幽门螺杆菌的关系及溃疡治疗的效果
Am J Gastroenterol. 1988 Mar;83(3):278-82.
9
Cure of duodenal ulcer associated with eradication of Helicobacter pylori.十二指肠溃疡的治愈与幽门螺杆菌的根除相关。
Lancet. 1990 May 26;335(8700):1233-5. doi: 10.1016/0140-6736(90)91301-p.
10
Colloidal bismuth in the treatment of duodenal ulceration: the benefit for the patient.胶体铋治疗十二指肠溃疡:对患者的益处。
Scand J Gastroenterol Suppl. 1989;157:16-20; discussion 21-2. doi: 10.3109/00365528909091046.

引用本文的文献

1
Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19.SARS-CoV-2 刺突蛋白与血液和血管内皮细胞的唾液酸化聚糖结合决定了 COVID-19 的严重发病机制。
Int J Mol Sci. 2023 Dec 1;24(23):17039. doi: 10.3390/ijms242317039.
2
When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples.当临床试验的特征需要按方案分析以及意向性分析结果才能得出可靠结论时:三个实例
J Clin Med. 2023 May 23;12(11):3625. doi: 10.3390/jcm12113625.
3
Role of Radiology and Laparoscopy in Childhood Peptic Ulcer Perforation.
放射学和腹腔镜在儿童消化性溃疡穿孔中的作用。
J Environ Public Health. 2022 Jul 20;2022:1211499. doi: 10.1155/2022/1211499. eCollection 2022.
4
Sequential versus concomitant therapy for eradication of Helicobacter Pylori in patients with perforated duodenal ulcer: A randomized trial.序贯疗法与联合疗法根除十二指肠溃疡穿孔患者幽门螺杆菌的随机试验
Saudi J Gastroenterol. 2016 Jul-Aug;22(4):309-15. doi: 10.4103/1319-3767.187605.
5
Advances in laparoscopy for acute care surgery and trauma.急性护理手术和创伤腹腔镜检查的进展。
World J Gastroenterol. 2016 Jan 14;22(2):668-80. doi: 10.3748/wjg.v22.i2.668.
6
How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly.如何有效使用铋剂四联疗法:优点、缺点与问题
Gastroenterol Clin North Am. 2015 Sep;44(3):537-63. doi: 10.1016/j.gtc.2015.05.003. Epub 2015 Jun 19.
7
Helicobacter pylori cag pathogenicity island's role in B7-H1 induction and immune evasion.幽门螺杆菌细胞毒素相关基因致病岛在B7-H1诱导及免疫逃逸中的作用
PLoS One. 2015 Mar 25;10(3):e0121841. doi: 10.1371/journal.pone.0121841. eCollection 2015.
8
Comparative analysis of anti-Helicobacter pylori activities of FEMY-R7 composed of Laminaria japonica and Oenothera biennis extracts in mice and humans.由海带和月见草提取物组成的FEMY-R7对小鼠和人类抗幽门螺杆菌活性的比较分析。
Lab Anim Res. 2015 Mar;31(1):7-12. doi: 10.5625/lar.2015.31.1.7. Epub 2015 Mar 20.
9
Anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract in mice and humans.由岩藻依聚糖和月见草提取物组成的FEMY-R7对小鼠和人类的抗幽门螺杆菌活性。
Lab Anim Res. 2014 Sep;30(3):131-5. doi: 10.5625/lar.2014.30.3.131. Epub 2014 Sep 29.
10
In vitro and in vivo anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract.由岩藻依聚糖和月见草提取物组成的FEMY-R7的体外和体内抗幽门螺杆菌活性
Lab Anim Res. 2014 Mar;30(1):28-34. doi: 10.5625/lar.2014.30.1.28. Epub 2014 Mar 24.